Updates are available Correction dated 2022-05-20
Click to view Correction: https://doi.org/10.1007/s12094-022-02855-2
-
Authors
Capdevila, Jaume http://orcid.org/0000-0003-0718-8619
Gómez, Ma Auxiliadora
Guillot, Mónica
Páez, David
Pericay, Carles
Safont, Maria José
Tarazona, Noelia
Vera, Ruth
Vidal, Joana
Sastre, Javier
- License Information
-
More Information
Article History
Accepted: 22 February 2022
First Online: 18 March 2022
Change Date: 20 May 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12094-022-02855-2
Declarations
:
: MJSA reports Advisory Board, Speaker and Other from Amgen, Merck, Sanofi, Servier and Pierre Fabre. JCC reports Advisory Board, Speaker and Grant from Bayer, Eisai, Ipsen, Adacap and Amgen; Advisory Board and Speaker from Novarti, Pfizer, Exelisis, Sanofi, Lilly, Huchmed and ITM and Advisory Board from Merck Sereno. JVB reports Advisory Board and Speaker from Merck Serono, BMS and Novartis and Speaker from Sanofi, MSD and Pierre Fabre. DPLB reports Honoraria from Amgen, Sanofi, Novartis; Consulting Advisory Role from Amgen, Ipsen, Servier; Research Funding from Merck and Travel Accommodation Expenses from Amgen, Merck, Roche, Lilly, Servier, Sanofi and Ipsen. MGM, RVG, CPP, NTL, JSV and MAGE have nothing to disclose.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: For this type of study formal consent is not required.
